Torigen, Inc

Torigen is committed to helping improve the lives of pets by harnessing the power of their immune systems to change the way cancer is treated with an individualized vaccine. Cancer affects nearly 10 million companion animals every year, yet pet owners may have limited knowledge of all available treatment options. Our experimental autologous prescription product, backed with over a decade of supporting research, uses the patients own tumor cells to create a personalized cancer treatment. Our goal is to empower veterinarians, through partnership and collaboration early in the diagnostic process, to be part of the solution

Veterinary cancer care,companion animal oncology,immunology,and biotechnology

Torigen, inc operates in the Veterinary services industry.

Torigen, inc's revenue is 11m - 100m

Torigen, inc has 11 - 50 employees.